Document is current
Any future updates will be listed below
-
Authors
Andersen, Rebecca Kjær
Ankjær, Peter https://orcid.org/0009-0000-5384-6825
Axelsen, Kasper Holst
Andersen, Linda Kahr
Vissing, John
Witting, Nanna
-
Funding
Funding for this research was provided by:
UCB
National Hospital
- License Information
-
More Information
Article History
Received: 11 March 2026
Revised: 17 April 2026
Accepted: 21 April 2026
First Online: 9 May 2026
Declarations
:
: All authors: Research funded partly by UCB. John Vissing: Consultant on advisory boards for Roche, Regeneron, Argenx BVBA, UCB Biopharma SPRL, and Horizon Therapeutics. Research, travel support, and/or speaker honoraria from Alexion Pharmaceuticals and UCB Biopharma SPRL. Nanna Witting: Study grant from UCB.
